JOANNE CROSSAN: Open Payments
NPI 1255631123 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 17 payments from 8 companies in 2025. Trend: 2023 $324 · 2024 $321 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $144 |
| Travere Therapeutics, Inc. | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
Products named: TARPEYO, FARXIGA, Empaveli, VOYXACT, Gazyva, Kerendia, VELPHORO.
Industry payments across SC — which companies pay providers there.
